Growth Hormone Treatment for Prader-Willi Syndrome

Maïthé Tauber1, Gwenaelle Diene2, Catherine Molinas3

  • 1Centre de référence du syndrome de Prader-Willi, Hôpital des Enfants, CHU Toulouse, France, 2Axe Pédiatrique du CIC 9302/INSERM. Hôpital des Enfants, Toulouse, France, 3INSERM U1043, Centre de Physiopathologie de Toulouse Purpan, UPS, France,

Insights

Recombinant human growth hormone (rhGH) therapy has transformed Prader-Willi syndrome (PWS) care, improving growth and body composition. Future focus must address co-morbidities not affected by rhGH for comprehensive patient well-being.

Area of Science:

  • Pediatric endocrinology
  • Metabolic disorders
  • Genetics

Background:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder affecting multiple body systems.
  • Recombinant human growth hormone (rhGH) is a key therapeutic agent for PWS, particularly for short stature.
  • The European Marketing Authorization for rhGH in PWS children marked a significant advancement in metabolic and body composition management.

Purpose of the Study:

  • To review the impact of rhGH on children and young adults with PWS.
  • To highlight the role of rhGH in improving linear growth, body composition, and socialization.
  • To identify areas for future research and clinical focus, including co-morbidities and care transition.

Main Methods:

  • Literature review of rhGH treatment in PWS.
  • Analysis of clinical outcomes related to growth, body composition, and socialization.
  • Discussion of PWS pathophysiology and co-morbidities.

Main Results:

  • rhGH treatment has significantly improved linear growth, body composition, and socialization in PWS patients.
  • rhGH has become a cornerstone of PWS management, facilitating multidisciplinary care.
  • The pathophysiology of associated hormonal deficiencies, including GH, is increasingly understood.

Conclusions:

  • rhGH therapy has revolutionized PWS care, offering substantial benefits for growth and metabolic parameters.
  • Addressing co-morbidities like feeding and behavioral issues is crucial for enhancing patient quality of life.
  • Improving the transition of care from adolescence to adulthood remains a significant challenge.

Related Concept Videos

Plant Hormones01:56

Plant Hormones

Plant hormones—or phytohormones—are chemical molecules that modulate one or more physiological processes of a plant. In animals, hormones are often produced in specific glands and circulated via the circulatory system. However, plants lack hormone-producing glands.
27.6K
Types of Hormones02:13

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
83.6K
Types of Hormones01:21

Types of Hormones

Hormones are classified into four main groups: steroids, eicosanoids, amino acid-based derivatives, and peptide hormones.
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
7.1K